GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Omaxe Ltd (BOM:532880) » Definitions » Net Income (Continuing Operations)

Omaxe (BOM:532880) Net Income (Continuing Operations) : ₹-6,854 Mil (TTM As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Omaxe Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Omaxe's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ₹-1,487 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-6,854 Mil.


Omaxe Net Income (Continuing Operations) Historical Data

The historical data trend for Omaxe's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omaxe Net Income (Continuing Operations) Chart

Omaxe Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,352.10 -1,616.10 -3,510.80 -4,059.10 -6,854.00

Omaxe Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,435.90 -1,469.80 -2,394.80 -1,502.80 -1,486.70

Omaxe Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-6,854 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omaxe  (BOM:532880) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Omaxe Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Omaxe's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Omaxe Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Omaxe Ltd (BOM:532880) » Definitions » Net Income (Continuing Operations)
Traded in Other Exchanges
Address
Omaxe House, 7, Local Shopping Centre, Kalkaji, New Delhi, IND, 110019
Omaxe Ltd is engaged in the real estate business. It carries on the construction, development, and sale of townships, residential, and commercial properties. Geographically, it derives prime revenue from India. The company's residential properties include The Lake, Omax plots, Celestia Royal Premier, Ambrosia, Celestia Grand, and The Resort. The company's commercial projects include Pearls Omaxe, Omaxe Square, Omaxe Chowk, and Omaxe Statue. The company derives almost all of its revenue from real estate projects.

Omaxe Headlines

No Headlines